This summary discusses recent developments regarding an investigation into the timing of Pfizer's COVID-19 vaccine announcement, which occurred just after the 2020 presidential election. It highlights claims made by former President Donald Trump and statements from a former Pfizer scientist.
• Pfizer announced its COVID-19 vaccine effectiveness two days after Joe Biden was declared the winner of the 2020 presidential election.
• Former President Trump questioned the timing of the announcement, suggesting it was intentionally delayed as a response to his administration's drug pricing policies.
• Trump referenced his executive order aimed at lowering prescription drug prices through comparisons with other countries, claiming that the vaccine results were planned to be released in October.
• Pfizer's CEO had indicated in September 2020 that the company would know the vaccine's efficacy by the end of October.
• Trump argued that positive vaccine news before the election would have influenced its outcome.
• The U. S. attorney’s office in Manhattan is investigating remarks made by Phil Dormitzer, a former Pfizer scientist, who allegedly indicated that the vaccine trial success announcement was postponed until after the election.
• Dormitzer left Pfizer in 2021 and now works for rival company GSK. Reports state that he confided to GSK executives about the timing of Pfizer's announcement.
• While Dormitzer disputes the claims attributed to him, prosecutors are examining notes taken by a GSK executive during their conversation.
• The investigation includes plans to interview additional individuals and has not yet involved Pfizer officials.
• Dormitzer asserted that he and his colleagues at Pfizer took all necessary steps to seek emergency use authorization for the vaccine as soon as possible.
• Pfizer has refuted any allegations of impropriety, maintaining that its announcement timing was determined by scientific data and FDA regulations.
• The review process for the vaccine's effectiveness involved independent experts who assessed its safety and effectiveness before the announcement on November 8.
• The Department of Justice is reviewing various claims regarding the announcement's timing and potential implications for the 2020 election.
The investigation into Pfizer's vaccine announcement raises questions about its timing in relation to the 2020 presidential election. As the DOJ examines various allegations, the outcome of the probe could reveal significant information regarding the vaccine's development process and its impact on the electoral landscape.
No comments:
Post a Comment